Home/ Stocks/ IXHL

Incannex Healthcare Limited Common Stock

IXHL XNAS

$3.49 +0.10 (+2.80%) ▲ 15-min delayed

Open

$3.38

High

$3.54

Low

$3.37

Volume

28.9K

Market Cap

$40.62M

About Incannex Healthcare Limited Common Stock

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 12 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2026	$0	$-3,883,000	$-0.35
Q2 2026	$0	$-6,521,000	$-0.02
Q1 2026	$0	$-6,407,000	$-0.02
FY 2025	$86.0K	$-46,885,000	$-1.35

Earnings & Analyst Ratings

Next Earnings: Thu, Nov 12, 2026

Calendar →

Related Market News

No specific coverage for IXHL yet. Check out our latest market news or earnings calendar.

Get IXHL Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Incannex Healthcare Limited Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.